Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Clinical trial NCT07197645 · RECRUITING

Trial details

NCT number: NCT07197645
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Bone Pain Metastatic Bone Tumor Bone Metastases in Subjects With Advanced Cancer

Start date: 2025-10-21
Primary completion: 2027-04-26
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.